Michael W. Dunne

5.5k citations
89 papers · 3.7k indexed · 1 hit paper · h-index 30
Topics
Antibiotics Pharmacokinetics and Efficacy (23 papers)Antimicrobial Resistance in Staphylococcus (21 papers)Urinary Tract Infections Management (14 papers)

In The Last Decade

Michael W. Dunne

86 papers receiving 3.5k citations

Hit Papers

Maraviroc for Previously Treated Patients with R5 HIV-1 I...20082026201420202008100200300400500

Peers

Michael W. Dunne
Comparison fields: 5 of 150
  • Infectious Diseases 1.9k
  • Epidemiology 1.0k
  • Public Health, Environmental and Occupational Health 861
  • Clinical Biochemistry 591
  • Pharmacology 563
Replace Vana Sypsa with:
Vana Sypsa Greece
Angela Chow Singapore
Amy Weintrob United States
Stefan Riedel United States
Satish K. Pillai United States
Snigdha Vallabhaneni United States
Daniel J. Skiest United States
Antonino Di Italy
Carlos Álvarez Colombia
Catherine E. Oldenburg United States
Michael W. Dunne relative to Vana Sypsa Greece Vana Sypsa's profile →
Citations per field
00.5×4.9×
Vana Sypsa · 1×
Citations per year

Countries citing papers authored by Michael W. Dunne

Since Specialization
Citations

This map shows the geographic impact of Michael W. Dunne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Dunne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Dunne more than expected).

Fields of papers citing papers by Michael W. Dunne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Dunne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Dunne. The network helps show where Michael W. Dunne may publish in the future.

Co-authorship network of co-authors of Michael W. Dunne

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Dunne. A scholar is included among the top collaborators of Michael W. Dunne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Dunne. Michael W. Dunne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 0
3 6
4 0
5 0
6 1
7 26
8 15
9 58
10 33
11 4
12
Maraviroc for Previously Treated Patients with R5 HIV-1 Infectionbreakdown →
570
13 57
14
Thomas Aquinas, Approaches to truth : the Aquinas lectures at maynooth, 1996-2001
4
15
Mind, Metaphysics and Value in the Thomistic and Analytical Traditions
7
16 107
17 3
18 49
19 9
20 59

About Michael W. Dunne

Michael W. Dunne is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Clinical Biochemistry, having authored 89 papers that have together received 3.7k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (23 papers), Antimicrobial Resistance in Staphylococcus (21 papers) and Urinary Tract Infections Management (14 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (236 citations), Virology (518 citations) and Infectious Diseases (1.9k citations). Michael W. Dunne has collaborated with scholars based in United States, United Kingdom and New Zealand. Frequent co-authors include Sailaja Puttagunta, Helen W. Boucher, George H. Talbot, Anita Das, Sik Hung Ng, James Baldassarre, Mark Wilcox, Michael T. Zelasky, Marc Wilson and Steve Felstead. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026